One of the biggest challenges in cancer treatment is that certain cancers reappear after chemotherapy-and an aggressive type ...

Artificial intelligence (AI) and socioeconomic factors enhance risk stratification for patients with acute myeloid leukemia (AML) post transplant, aiming to reduce hospital readmissions and disease ...

One of the biggest challenges in cancer treatment is that certain cancers reappear after chemotherapy—and an aggressive type ...

If there are no dose-limiting toxicities, the company will test the CAR T-cell therapy at higher doses in more patients with FLT3-expressing refractory AML.

Amir Fathi, MD, leukemia specialist at Massachusetts General Hospital, discusses the importance of advocacy by both patients ...